Search Results

Aveanna Healthcare Holdings Inc. today announced that its management team will attend the UBS Healthcare Services Cape Cod Summit in Chatham, MA on Tuesday, June 4, 2024, and the Jefferies Global Healthcare Conference in New York on Wednesday, June 5, 2024.

EVŌQ Nano announced its antimicrobial medical device platform has demonstrated effectiveness against the world’s leading pathogens implicated in healthcare-associated infections, which are some of the most common complications of hospital care.

BioMatrix Specialty Infusion Pharmacy (“BioMatrix” or “The Company”) announced today the sale of the majority interests of the company from Acon Investments & Triton Pacific Healthcare to Frazier Healthcare Partners (“Frazier”).

Celldex Therapeutics, Inc. announced that management will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 6th at 10:00 am ET.

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, announced that the Company will participate in two upcoming healthcare conferences in June.

Sirona Biochem Corp. is pleased to announce that its innovative anti-aging ingredient, GlycoProteMim™, has been featured in Stonegate Healthcare’s newly published research report, “Novel Treatments for Age-Related Skin Problems.” The report provides an in-depth analysis of the latest advancements in the $12.5 billion anti-aging skincare market.

Immunocore Holdings plc today announced that management will participate in the Jefferies Global Healthcare Conference.

vTv Therapeutics Inc. announced that it has closed a private placement to healthcare-focused institutional investors, including a life sciences-focused institutional investor, Samsara BioCapital, LLC and the JDRF T1D Fund, of 464,377 shares of common stock at a price of $11.81 per share, which is the 45 day VWAP ended on January 29, 2024, and pre-funded warrants for 3,853,997 shares of common stock in lieu of vTv common stock in a private placement financing.